Back to blog

Mitochondrial Dysfunction and Aging: What Happens Inside Your Energy Factories

Mitochondrial dysfunction is the progressive loss of ATP production efficiency that occurs with age, accompanied by increased oxidative stress and chronic inflammation. It is one of the 12 hallmarks of aging.

By Dr. Miguel Ángel Fernández Toránmitocondriasenvejecimientoestrés oxidativoNAD+
Mitochondrial Dysfunction and Aging: What Happens Inside Your Energy Factories

Mitochondrial dysfunction is the progressive loss of ATP production efficiency that occurs with age, accompanied by increased oxidative stress and chronic inflammation. It is one of the 12 hallmarks of aging.

Summarize with AI:ChatGPTClaudeGemini

Mitochondrial dysfunction in aging is the progressive loss of efficiency with which mitochondria produce ATP, recycle damaged components and coordinate signals for stress, inflammation and repair. It does not necessarily mean you have a genetic mitochondrial disease. It means that, with age, many tissues lose energetic reserve and quality control. López-Otín et al. identify mitochondrial dysfunction as one of the 12 hallmarks of aging (Cell, 2023, PMID: 36599349).

The useful thesis is simple: mitochondria are not "fixed" by one supplement. They are protected by well-dosed physiological demand — exercise, strength training, sleep, nutrition, daylight, recovery and inflammation control — and by measuring whether functional capacity improves. In 2026, the literature focuses less on "more energy" and more on mitochondrial quality control: biogenesis, fusion, fission, mitophagy, nucleus-mitochondria communication and stress response.

Quick answer: what to know

  • It is not one diagnosis: fatigue, brain fog and slow recovery can have many causes. Age-related mitochondrial dysfunction is assessed as loss of reserve, not through one magic blood test.
  • The best clinical entry point is usually functional: VO₂ max, ventilatory or lactate thresholds, strength, recovery, sleep, HRV and cardiometabolic markers often say more than isolated advanced biomarkers.
  • Exercise and strength remain the base intervention: a 2026 review on exercise and mitochondrial quality control summarizes effects on biogenesis, mitophagy, mitochondrial dynamics and inflammation.
  • NAD+, CoQ10, carnitine and ozone are not shortcuts: they can make sense in selected cases, but human evidence does not justify promising mitochondrial rejuvenation or replacing training, sleep or diagnosis.
  • Measurable response matters: if a protocol does not change energy, pain, performance, sleep, glucose, inflammation or exercise tolerance, it probably changed the story more than the biology.

Mitochondrial disease is not the same as age-related mitochondrial decline

Search results often mix two different conversations. Mitochondrial diseases are rare, often genetic disorders that can affect the brain, muscle, heart, liver, kidneys, vision, hearing or endocrine system and require specialist clinical care. Age-related mitochondrial dysfunction is the gradual decline in energetic efficiency, oxidative balance, calcium handling, cellular communication and mitochondrial recycling.

Situation What it means What to do
Mitochondrial disease Complex multisystem presentation, sometimes inherited, with neurological, muscular, cardiac, liver, visual, hearing or endocrine signs. Medical referral, clinical genetics, neurology/metabolic medicine and specialised testing.
Age-related decline Gradual loss of reserve: lower exercise tolerance, slow recovery, reduced metabolic flexibility, inflammation and lower stress resilience. Measure function, rule out common causes and build a training, sleep, nutrition and follow-up plan.
Unexplained fatigue It may feel "mitochondrial", but it can also be anaemia, thyroid disease, sleep apnoea, low energy availability, depression, medication, infection or overtraining. Do not jump straight to supplements. Start with medical history, basic labs, sleep, medication, training load and red flags.

When this is not "normal aging"

  • Neurological: ptosis, ophthalmoplegia, seizures, ataxia, unexplained visual or hearing loss, severe migraines with neurological signs or rapid deterioration.
  • Muscular: progressive weakness, marked exercise intolerance from early adulthood, rhabdomyolysis, myoglobinuria or disproportionate muscle pain.
  • Cardiometabolic: cardiomyopathy, unexplained arrhythmias, unusual-onset diabetes, lactic acidosis or liver/kidney involvement combined with muscle or neurological symptoms.
  • Family pattern: maternal inheritance, several systems affected in one person, or relatives with combinations of deafness, diabetes, myopathy, epilepsy or cardiomyopathy.

If these signs appear, the next step is not self-starting NAD+, CoQ10 or biohacking. It is medical assessment through neurology, clinical genetics, metabolic medicine or cardiology depending on the presentation. Preventive medicine works with functional reserve; mitochondrial diseases require a different level of urgency.

What Mitochondria Are and What They Actually Do

Mitochondria are organelles present in nearly every cell in the body. A heart muscle cell can contain more than 5,000 mitochondria. A neuron, several thousand. The reason is straightforward: they generate the vast majority of ATP the body needs to function.

But reducing mitochondria to "energy factories" misses a lot. They also regulate programmed cell death (apoptosis), control intracellular calcium homeostasis, participate in steroid hormone synthesis, and act as sensors of the cell's metabolic state. They have their own DNA — mitochondrial DNA (mtDNA) — inherited exclusively from the mother, and can replicate independently of the nucleus.

How They Produce ATP: The Electron Transport Chain

The core process is oxidative phosphorylation, which occurs on the inner mitochondrial membrane through five protein complexes (Complex I through V). The simplified flow:

  1. Nutrients (glucose, fatty acids, amino acids) are broken down in the cytosol and mitochondrial matrix, generating NADH and FADH₂.
  2. NADH and FADH₂ donate their electrons to Complexes I and II of the respiratory chain.
  3. Electrons flow through to Complex IV, where they combine with oxygen to form water (H₂O).
  4. That electron flow pumps protons (H⁺) from the matrix to the intermembrane space, creating an electrochemical gradient.
  5. Complex V (ATP synthase) uses that gradient to manufacture ATP.

Under aerobic conditions, a cell can obtain roughly 30-32 ATP molecules per glucose molecule, depending on tissue and metabolic context. When mitochondrial efficiency fails, the cell relies more on less efficient pathways, tolerates exertion poorly and may generate more reactive oxygen species (ROS). The issue is not that ROS are always "bad": at low levels they are adaptive signals; in excess, or when recycling fails, they damage lipids, proteins and DNA.

What Mitochondrial Dysfunction Means

Three characteristics define mitochondrial dysfunction in the context of aging:

Feature What happens Consequence
Loss of efficiency Respiratory chain complexes deteriorate, especially Complex I Less ATP produced per unit of oxygen consumed
Increased ROS Electrons escape the chain before reaching Complex IV Free radicals that damage lipids, proteins, and mtDNA itself
Mitophagy failure The recycling system for damaged mitochondria loses efficiency Accumulation of defective mitochondria inside cells

Miwa et al. described this cycle in detail in 2022: mitochondrial dysfunction is both a cause and consequence of cellular senescence, and the two processes mutually reinforce each other (J Clin Invest, 2022, PMID: 35775483).

Mechanisms of Decline: Why Things Get Worse With Age

Mitochondrial deterioration is not a single event — it is the convergence of several processes that accelerate as years pass:

1. Accumulation of mtDNA Mutations

Unlike nuclear DNA, mtDNA has limited repair capacity and is directly exposed to the ROS generated by the respiratory chain. With age, different studies describe accumulation of mtDNA mutations and deletions, although burden varies by tissue, method and person. Scheubel et al. documented reduced Complex I activity in failing human myocardium in relation to respiratory-chain alterations (J Am Coll Cardiol, 2002, PMID: 12505231). The clinical point is not to look for one universal percentage; it is to understand why high-energy tissues tolerate cumulative loss of mitochondrial quality poorly.

2. Cascading Oxidative Damage

ROS do not only damage mtDNA. They attack the lipids of the inner mitochondrial membrane, altering its fluidity and compromising proton transport efficiency. They attack the proteins of the respiratory complexes, reducing their activity. And they attack mitophagy proteins, making it harder to recycle damaged mitochondria. A self-reinforcing cycle: more oxidative damage → worse function → more ROS → more damage. Melatonin enters this story through its circadian and antioxidant roles, which we unpack in this guide to melatonin and ageing.

3. NAD+ Decline and Sirtuin Collapse

NAD+ is an indispensable cofactor for the electron transport chain and for the sirtuins, proteins that regulate DNA repair and mitochondrial biogenesis. Massudi et al. documented that NAD+ levels in human tissue drop approximately 50% between ages 40 and 60 (PLoS One, 2012, PMID: 22848760). That fall means less energy available to repair damaged mtDNA, less activation of SIRT1 and SIRT3 (which protect mitochondrial function), and less biogenesis of new mitochondria.

4. Mitophagy Failure

Mitophagy is the process by which damaged mitochondria are tagged (primarily via the PINK1 and Parkin proteins) and degraded inside lysosomes. With age, this quality control system becomes less efficient. The result is an accumulation of defective mitochondria that keep generating ROS but produce little ATP. In neurodegenerative diseases like Parkinson's, failure in PINK1-Parkin is one of the genetically identified mechanisms.

5. Loss of Mitochondrial Dynamics

Mitochondria are not fixed batteries. They fuse, divide, move inside cells and communicate with the nucleus. This dynamic network lets cells mix healthy contents, isolate damaged parts and adapt to energetic demand. Reviews from 2024-2026 describe how aging disrupts this system: poorer fusion/fission, weaker mitophagy, lower biogenesis and more inflammatory signaling. In practical terms, it is not enough to have "more mitochondria"; the network has to renew well.

Symptoms of Mitochondrial Dysfunction in Aging

Mitochondrial dysfunction does not produce a single, specific symptom. It produces a gradual loss of physiological reserve that manifests differently depending on the affected tissue:

  • Chronic fatigue and low energy: the most universal symptom. Cells cannot produce enough ATP to maintain all their functions.
  • Slow recovery from exercise: muscles take longer to replenish ATP and clear accumulated lactate.
  • Reduced exercise tolerance: VO₂max declines with age partly because muscular mitochondrial efficiency decreases.
  • Cognitive impairment: the brain consumes 20% of the body's ATP despite representing only 2% of body weight. Neurons are especially vulnerable to mitochondrial dysfunction.
  • Increased systemic inflammation: damaged mitochondria release molecular signals (mitochondrial DAMPs, including free mtDNA) that activate inflammatory pathways like the NLRP3 inflammasome.
  • Muscle mass loss (sarcopenia): muscle regeneration requires adequate mitochondrial function to support protein synthesis.

Relationship With Chronic Diseases of Aging

Mitochondrial dysfunction is not just an aging marker. It is observed in many chronic diseases and may contribute to progression, but it rarely acts alone. Miwa 2022, Somasundaram 2024, Zhang 2025 and Budinger/Chandel 2025 describe it as a network of signaling, cellular quality control, inflammation and metabolism; not as a single explanation for every disease.

This table should be read with caution. Mitochondria participate in many processes, but that does not mean every disease can be explained or treated through mitochondria alone. Clinically, the relationship helps us ask better questions: functional capacity, metabolism, inflammation, sleep, medication, exercise and cardiovascular risk.

Area What is observed Prudent reading
Neurodegeneration In Alzheimer's and Parkinson's, researchers study changes in mitophagy, calcium handling, ROS, inflammation and mitochondria-nucleus communication. In Parkinson's, genes such as PINK1, Parkin and LRRK2 point directly to mitochondrial quality control. Mechanistic association, not a diagnosis. Progressive neurological symptoms need medical evaluation, not a supplement protocol.
Heart The myocardium depends heavily on oxidative phosphorylation. Scheubel et al. observed lower Complex I activity in failing human myocardium. Relevant to functional reserve, aerobic capacity and cardiometabolic risk. It does not make CoQ10 or NAD+ universal heart treatments.
Diabetes and metabolism Insulin resistance, visceral fat, skeletal muscle and oxidative efficiency influence one another. Mitochondria are one part of metabolism, not the whole engine. Start with glucose/insulin, ApoB, blood pressure, waist, muscle, diet, sleep and exercise. Add advanced markers only if they change the plan.
Sarcopenia and fatigue Aging muscle often shows poorer biogenesis, mitophagy, mitochondrial quality and recovery after load. This connects with lower strength, lower VO₂ max and greater vulnerability to inactivity. The base intervention is trainable: strength, enough protein, zone 2, sleep and progressive loading. The reading should be functional, not only molecular.
Cancer Many tumors reprogram metabolism. Some rely more on glycolysis; others maintain or exploit mitochondrial functions to grow, survive or modulate the microenvironment. Do not frame this as "mitochondria cause cancer". In oncology, any metabolic intervention needs the treating team's context.

How to Measure Mitochondrial Function

Directly evaluating mitochondrial function in clinical practice is not straightforward. There is no single blood test that resolves it. What exists are indirect markers and functional tests that provide useful information:

The measurement ladder: from basic to advanced

Step What to look at Why it matters
1. Rule out common causes CBC, ferritin, B12, folate, TSH/free T4, HbA1c, kidney/liver function, vitamin D, medication, alcohol, sleep, sleep apnoea, energy intake and mood. Fatigue, brain fog and poor recovery should not be labelled "mitochondrial" before common, treatable causes are checked.
2. Measure function VO₂ max, ventilatory or lactate threshold, strength, power, body composition, HRV, sleep and perceived recovery. Mitochondria matter because they change what you can do. Functional capacity is usually more actionable than one isolated marker.
3. Add support markers Glucose/insulin, ApoB, hsCRP, suPAR, CoQ10, Oxytest/MDA, resting or exercise lactate, NAD+/NADH in selected labs. Useful when they guide a decision: supplementation, training adjustment, inflammation work-up, medication review or response tracking.
4. Specialist testing Genetics, muscle biopsy, respiratory-chain enzyme studies or advanced metabolic analyses. Reserved for genuine suspicion of mitochondrial disease or multisystem presentations, not routine wellness assessment.

VO₂max: The Best Clinical Proxy

VO₂max (maximal oxygen consumption) is the clinical indicator with the most support for evaluating cardiorespiratory capacity. It integrates heart, lungs, blood, muscle and peripheral oxygen extraction, which makes it a practical proxy for muscular mitochondrial reserve rather than an isolated mitochondrial measurement. Mandsager et al. demonstrated in 2018 that each additional MET of cardiorespiratory capacity is associated with a 13% reduction in all-cause mortality (JAMA Netw Open, 2018, PMID: 30646252).

VO₂max falls approximately 10% per decade from age 30 in the absence of training. But that decline is not solely due to lost cardiovascular capacity — much of it reflects reduced muscular mitochondrial efficiency. At Progevita, the VO₂max assessment (€140) using a Q-NRG gas analyzer is performed on a treadmill or cycle ergometer and is standard in the optimization protocol.

Lactate During Exercise

When mitochondrial function fails, muscle depends more on anaerobic glycolysis, which produces lactate as a byproduct. Measuring blood lactate during progressive exercise identifies the lactate threshold — the point where lactate exceeds clearance capacity. A low lactate threshold for a given exercise intensity indicates poor mitochondrial efficiency.

Complementary Biochemical Markers

Marker What it indicates How to interpret it
NAD+/NADH ratio Availability of mitochondrial cofactors Useful in research and some advanced labs, but there is no universal "optimal" value across all tissues.
Plasma CoQ10 Cofactor for Complexes I-III; decreases with age Most useful with statins, heart failure, selected fatigue cases or suspected deficiency; not a standalone diagnosis.
Urinary 8-OHdG Oxidative damage to DNA (including mtDNA) A signal of oxidative stress, not a mitochondria-specific marker.
Oxidative stress (Oxytest) MDA in urine: lipids oxidized by ROS Can help track trend when combined with symptoms, sleep, exercise, inflammation and glucose.
mtDNA copy number Mitochondrial density in blood cells Interesting but variable by tissue and method. Better for context than one-off decisions.
Resting blood lactate Signal of systemic mitochondrial dysfunction if elevated < 2 mmol/L at rest

The responsible reading is layered. First, rule out common causes of fatigue and low exercise tolerance. Second, measure function: VO₂ max, ventilatory or lactate threshold, strength, body composition, sleep and recovery. Third, use markers such as Oxytest, CoQ10, glucose/insulin, hsCRP or suPAR when they change a decision. A combined picture is usually more useful than chasing one "mitochondrial test".

Mitohormesis and UPRmt: why "more antioxidants" is not always better

Mitochondria do not only produce energy: they also send signals. A small amount of redox stress during exercise, heat, cold exposure, well-indicated fasting or muscle loading can activate adaptive pathways such as AMPK, PGC-1α, Nrf2, mitophagy and the mitochondrial unfolded protein response (UPRmt). That signal helps renew the mitochondrial network and prepares the cell for the next challenge.

So the modern reading is not "remove every free radical". It is stress dose + enough recovery. In some contexts, high-dose antioxidants may blunt training adaptations. In others, correcting deficiency or excess oxidative stress can be reasonable. Context decides: disease, medication, diet, exercise load, sleep and biomarkers. The goal is not to switch ROS off; it is to keep adaptive signaling from becoming chronic damage.

Interventions: what is best supported and what remains a promise

Mitochondrial function is not fixed. Muscle, heart, brain and adipose tissue still respond to load, recovery, nutrients and stress. The question is not "which supplement activates mitochondria?", but which intervention changes a real metric: VO₂ max, lactate threshold, strength, glucose, sleep, fatigue, pain or recovery.

Intervention Useful evidence Practical reading
Aerobic exercise and zone 2 The most consistent support. A 2026 review on exercise and mitochondrial quality control describes effects on biogenesis, mitophagy, fusion/fission, inflammation and metabolism. The base of the plan. 150-300 min/week of aerobic work, adjusted to level and recovery, usually matters more than any advanced therapy.
Strength training Protects muscle mass, insulin sensitivity, functional reserve and energy use. Central in sarcopenia prevention. 2-4 sessions/week, progressive, with technique and recovery. Without muscle, mitochondria lose their most trainable organ.
Sleep and circadian rhythm Mitochondria respond to timing of food, light, activity and rest. Poor sleep worsens glucose, appetite, recovery and oxidative stress. Before adding molecules: timing, daylight, dinner, alcohol, sleep apnoea, pain and night-time activation.
NAD+, NMN and NR The NAD+-mitochondria link is strong in biology. Human evidence is more uneven: several studies raise NAD+ in blood or tissue, but this does not prove universal clinical rejuvenation. Can be explored for fatigue, poor recovery or a measured medical protocol. Read it alongside our NAD+ therapy guide, not as a shortcut.
CoQ10 Biologically plausible as an electron carrier, with better evidence in specific contexts such as heart failure, statin use or deficiency. Consider when there is indication, medication context or low levels. Do not use it as proof that "mitochondria are failing".
Carnitine Involved in fatty-acid transport. May help with deficiency or selected profiles, but not a general solution for fatigue. Assess diet, kidney function, medication, symptoms and goal. Better inside a plan than as an isolated capsule.
Fasting or energy restriction Activates AMPK, lowers mTOR and may support autophagy/mitophagy in models. In humans, benefit depends on adherence, muscle mass, sleep and metabolic context. Useful when it improves glucose, weight, inflammation or energy. A poor fit with low weight, eating disorders, frailty, high training load or incompatible medication.
Ozone therapy and redox hormesis The Nrf2/controlled oxidative stress hypothesis is plausible, but specific evidence as a mitochondrial longevity therapy remains limited. It is not a direct mitochondrial therapy or first-line intervention. Only with indication, safety and follow-up. It should be framed as experimental/adjunctive support, not guaranteed mitochondrial repair.

This ranking matters because it avoids the common biohacking mistake: chasing molecular pathways while ignoring tissue. If the plan does not improve aerobic capacity, strength, load tolerance, sleep and metabolic control, mitochondria are not receiving the signals that most consistently remodel them.

The role of mitochondrial dysfunction within the 12 hallmarks

One of the most important points in López-Otín et al.'s 2023 review is that mitochondrial dysfunction does not act alone. It interacts with several other hallmarks:

  • With cellular senescence: dysfunctional mitochondria activate inflammasomes and contribute to the SASP, the inflammatory secretory phenotype of senescent cells.
  • With genomic instability: mitochondrial ROS can damage nuclear DNA, while nuclear DNA damage can impair mitochondrial maintenance.
  • With inflammaging: mtDNA released from damaged mitochondria can act as a danger signal that activates innate immune pathways and feeds chronic inflammation.
  • With sirtuin dysregulation: lower NAD+ can reduce activity of SIRT3, a key mitochondrial sirtuin involved in antioxidant defense and metabolic regulation.

This is why the best mitochondrial interventions are not isolated "mitochondrial hacks". They are the boring-but-powerful inputs that improve several systems at once: aerobic capacity, muscle, glucose handling, sleep, inflammation and recovery.

Frequently Asked Questions

What is mitochondrial dysfunction in simple terms?

It is when mitochondria — the structures inside cells that generate energy — start working less well. They produce less ATP (the body's energy molecule), generate more free radicals that damage cells, and the system that should recycle damaged mitochondria also fails. With age, this happens in all tissues, but shows first in those that need the most energy: muscle, heart, and brain.

Is mitochondrial dysfunction the same as mitochondrial disease?

No. A mitochondrial disease is usually a complex clinical disorder, often genetic, that requires specialist assessment. Age-related mitochondrial dysfunction describes a gradual loss of efficiency and cellular quality control. If there are severe neurological, cardiac or muscular symptoms, visual/hearing problems, lactic acidosis or multisystem involvement, do not attribute it to "aging": it needs medical evaluation.

What are the symptoms of mitochondrial dysfunction related to aging?

The most common are persistent fatigue without obvious cause, slow recovery after exercise, lower tolerance to physical effort, difficulty concentrating, and greater susceptibility to infections or inflammation. These symptoms are not specific to mitochondrial dysfunction: many conditions share them. If they appear gradually from ages 40-50, they can justify assessing aerobic capacity, strength, sleep, metabolism and common medical causes; they do not confirm a mitochondrial problem by themselves.

How is mitochondrial function measured clinically?

There is no single test. The most useful approach combines functional testing — VO₂ max, ventilatory or lactate thresholds, strength and recovery — with clinical context and selected support markers such as oxidative stress, glucose/insulin, inflammation or CoQ10 when relevant. The goal is not to label the mitochondria; it is to identify what limits energy and which intervention changes the outcome.

Can mitochondrial function improve at any age?

Functional capacity can improve at many ages, although baseline health, disease and muscle mass matter. The best-supported levers are aerobic exercise, strength training, sleep, adequate nutrition and metabolic control. NAD+, CoQ10, carnitine or fasting may have a place in selected profiles, but they should not replace the main signals or be sold as mitochondrial rejuvenation.

What is the connection between NAD+ and mitochondria?

NAD+ participates in redox reactions, energy metabolism and cellular repair pathways. It also connects with mitochondrial sirtuins such as SIRT3. But "raising NAD+" is not automatically the same as rejuvenating mitochondria: levels differ by tissue, many tests do not capture the relevant compartment and human clinical outcomes remain limited.

Does ozone therapy have any effect on mitochondria?

It may have indirect effects on the redox environment in which mitochondria operate, especially through hormetic signaling and Nrf2. The prudent version is this: it is not a direct mitochondrial therapy and not a standard longevity treatment. If used, it needs indication, safety screening, follow-up and a clear response metric.

When should I be concerned about my mitochondrial function?

It deserves attention if there is persistent fatigue, a marked drop in effort tolerance, unusually slow recovery, weakness, neurological symptoms or multisystem involvement. In prevention, the question is calmer: is your aerobic capacity, strength, sleep and metabolism below what is expected for your age? That is where measurement and action make sense before disease appears.

References

  1. López-Otín C et al. "Hallmarks of aging: An expanding universe". Cell. 2023;186(2):243-278. PMID: 36599349.
  2. López-Otín C et al. "The Hallmarks of Aging". Cell. 2013;153(6):1194-1217. PMID: 23746838.
  3. Miwa S et al. "Mitochondrial dysfunction in cell senescence and aging". J Clin Invest. 2022;132(13):e158447. PMID: 35775483.
  4. Somasundaram I et al. "Mitochondrial dysfunction and its association with age-related disorders". Front Physiol. 2024;15:1384966. DOI: 10.3389/fphys.2024.1384966.
  5. Zhang X et al. "Mitochondrial dysfunction in the regulation of aging and aging-related diseases". Cell Commun Signal. 2025;23:290. DOI: 10.1186/s12964-025-02308-7. PMID: 40537801.
  6. Budinger GRS, Chandel NS. "Mitochondria dysfunction: cause or consequence of physiologic aging?". Genes Dev. 2025;39(15-16):917-919. DOI: 10.1101/gad.353106.125. PMID: 40645665.
  7. Cai T, Li Y, Zhang Y, Li C, Li S, Zhang Q. "The role of exercise-mediated mitochondrial quality control remodeling in aging". Front Cell Dev Biol. 2026;14:1792645. DOI: 10.3389/fcell.2026.1792645.
  8. Parikh S et al. "Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society". Genet Med. 2015;17(9):689-701.
  9. Cleveland Clinic. "Mitochondrial Diseases". Patient resource.
  10. Scheubel RJ et al. "Dysfunction of mitochondrial respiratory chain complex I in human failing myocardium". J Am Coll Cardiol. 2002;40(12):2174-2181. PMID: 12505231.
  11. Massudi H et al. "Age-associated changes in oxidative stress and NAD+ metabolism in human tissue". PLoS One. 2012;7(7):e42357. PMID: 22848760.
  12. Mandsager K et al. "Association of cardiorespiratory fitness with long-term mortality among adults undergoing exercise treadmill testing". JAMA Netw Open. 2018;1(6):e183605. PMID: 30646252.
  13. Radak Z et al. "Exercise effects on physiological function during aging". Free Radic Biol Med. 2019;132:33-41. PMID: 30389495.
  14. Yusri K et al. "The role of NAD+ metabolism and its modulation of mitochondria in aging and disease". npj Metab Health Dis. 2025;3:26. DOI: 10.1038/s44324-025-00067-0.

This article is for informational purposes and does not replace individual medical consultation. Fatigue, exercise intolerance or suspected mitochondrial disease should be assessed in clinical context before starting supplements, infusions or advanced protocols.

Want to understand your energetic reserve? Talk to our medical team and design an assessment with VO₂max, strength, sleep, biomarkers and a measurable training, recovery and nutrition plan at Balneario de Cofrentes, Valencia.

mitocondriasenvejecimientoestrés oxidativoNAD+ATPlongevidad
Start Plan